Literature DB >> 11162904

IGF-I promotes Schwann cell motility and survival via activation of Akt.

H L Cheng1, M Steinway, C L Delaney, T F Franke, E L Feldman.   

Abstract

We previously reported insulin-like growth factor-I (IGF-I) promotes Schwann cell (SC) motility and rescues SC from apoptosis induced by serum deprivation. This effect is mediated by phosphatidylinositol-3 (PI-3) kinase. In the current study, we examined the role of Akt, a downstream kinase of PI-3K, in SC motility and IGF-I mediated protection from apoptosis. IGF-I induces Akt phosphorylation at Ser473, an event which may be blocked by pretreatment with a PI-3K inhibitor, LY294002. In dominant negative K179M Akt (K179M) transfected SC, however, Akt is not activated in response to IGF-I. In addition, IGF-I is unable to promote SC motility and survival in K179M SC. These results suggest a critical role for Akt in IGF-I mediated motility and survival in SC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11162904     DOI: 10.1016/s0303-7207(00)00324-5

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  18 in total

1.  Schwann cell-specific ablation of laminin gamma1 causes apoptosis and prevents proliferation.

Authors:  Wei-Ming Yu; M Laura Feltri; Lawrence Wrabetz; Sidney Strickland; Zu-Lin Chen
Journal:  J Neurosci       Date:  2005-05-04       Impact factor: 6.167

Review 2.  Glial cells: old cells with new twists.

Authors:  Ugo Ndubaku; Maria Elena de Bellard
Journal:  Acta Histochem       Date:  2007-12-18       Impact factor: 2.479

3.  Growth factor signaling induces metastasis genes in transformed cells: molecular connection between Akt kinase and osteopontin in breast cancer.

Authors:  Guoxin Zhang; Bin He; Georg F Weber
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

4.  Nerve growth factor regulates the expression of the cholinergic locus and the high-affinity choline transporter via the Akt/PKB signaling pathway.

Authors:  Beata Madziar; Sonia Shah; Martina Brock; Rebecca Burke; Ignacio Lopez-Coviella; Ann-Christin Nickel; Esra Betul Cakal; Jan Krzysztof Blusztajn; Brygida Berse
Journal:  J Neurochem       Date:  2008-09-13       Impact factor: 5.372

5.  Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells.

Authors:  Amandine Hurbin; Jean-Luc Coll; Laurence Dubrez-Daloz; Bernard Mari; Patrick Auberger; Christian Brambilla; Marie-Christine Favrot
Journal:  J Biol Chem       Date:  2005-03-14       Impact factor: 5.157

6.  Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.

Authors:  Zekuan Xu; Yi Zhang; Jiakai Jiang; Yang Yang; Ruihua Shi; Bo Hao; Zhihong Zhang; Zuhu Huang; Jin W Kim; Guoxin Zhang
Journal:  BMC Cancer       Date:  2010-04-27       Impact factor: 4.430

7.  Hydrogen peroxide-induced Akt phosphorylation regulates Bax activation.

Authors:  Mahdieh Sadidi; Stephen I Lentz; Eva L Feldman
Journal:  Biochimie       Date:  2009-02-06       Impact factor: 4.079

8.  Inflammatory pain-induced signaling events following a conditional deletion of the N-methyl-D-aspartate receptor in spinal cord dorsal horn.

Authors:  H T Cheng; M Suzuki; D M Hegarty; Q Xu; A R Weyerbacher; S M South; M Ohata; C E Inturrisi
Journal:  Neuroscience       Date:  2008-06-19       Impact factor: 3.590

9.  Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination.

Authors:  Toru Ogata; Satoru Iijima; Shinya Hoshikawa; Toshiki Miura; Shin-ichi Yamamoto; Hiromi Oda; Kozo Nakamura; Sakae Tanaka
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

10.  Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells.

Authors:  Ernesto Bernal-Mizrachi; Szabolcs Fatrai; James D Johnson; Mitsuru Ohsugi; Kenichi Otani; Zhiqiang Han; Kenneth S Polonsky; M Alan Permutt
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.